Clinical trial
Tolerability and Acceptability of Fibersol-2 (Resistant Maltodextrin) in Healthy and Diarrheal Children Followed by a Randomized Clinical Trial to Evaluate the Efficacy of Fibersol-2 in Diarrheal Children 1-3 Years Old
NCT03565393 is registered in ClinicalTrials.gov with International Centre for Diarrhoeal Disease Research, Bangladesh as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Tolerability and Acceptability of Fibersol-2 (Resistant Maltodextrin) in Healthy and Diarrheal Children Followed by a Randomized Clinical Trial to Evaluate the Efficacy of Fibersol-2 in Diarrheal Children 1-3 Years Old
- Lead sponsor
- International Centre for Diarrhoeal Disease Research, Bangladesh
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- March 19, 2018
- Completion date
- March 31, 2019
- Enrollment
- 92 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.